BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19698256)

  • 21. [Investigation of the cutoff value of a serum 1,3-beta-D-glucan assay for early diagnosis of invasive fungal infection in Chinese hematopoietic stem cell transplant recipients].
    Ji Y; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):405-7. PubMed ID: 19031745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever.
    Ellis M; Al-Ramadi B; Finkelman M; Hedstrom U; Kristensen J; Ali-Zadeh H; Klingspor L
    J Med Microbiol; 2008 Mar; 57(Pt 3):287-295. PubMed ID: 18287290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
    Pazos C; Pontón J; Del Palacio A
    J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of invasive fungal infections using real-time PCR assay in paediatric acute leukaemia induction.
    Mandhaniya S; Iqbal S; Sharawat SK; Xess I; Bakhshi S
    Mycoses; 2012 Jul; 55(4):372-9. PubMed ID: 22420668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.
    Azoulay E; Guigue N; Darmon M; Mokart D; Lemiale V; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Rabbat A; Bretagne S; Lebert C; Meert AP; Benoit D; Pene F
    Oncotarget; 2016 Apr; 7(16):21484-95. PubMed ID: 26910891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
    Persat F; Ranque S; Derouin F; Michel-Nguyen A; Picot S; Sulahian A
    J Clin Microbiol; 2008 Mar; 46(3):1009-13. PubMed ID: 18160456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
    Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
    Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients.
    Levesque E; Rizk F; Noorah Z; Aït-Ammar N; Cordonnier-Jourdin C; El Anbassi S; Bonnal C; Azoulay D; Merle JC; Botterel F
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
    Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
    Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation.
    Reischies FM; Prattes J; Woelfler A; Eigl S; Hoenigl M
    Transpl Infect Dis; 2016 Jun; 18(3):466-70. PubMed ID: 26992092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of (1, 3)-β-D-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts.
    Theel ES; Jespersen DJ; Iqbal S; Bestrom JE; Rollins LO; Misner LJ; Markley BJ; Mandrekar J; Baddour LM; Limper AH; Wengenack NL; Binnicker MJ
    Mycopathologia; 2013 Feb; 175(1-2):33-41. PubMed ID: 22945270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The performance of (1, 3)-beta-D-glucan and Aspergillus galactomannan measurement for early diagnosis of invasive aspergillosis in patients with hematological diseases].
    Horiguchi Y
    Kansenshogaku Zasshi; 2004 Jul; 78(7):566-73. PubMed ID: 15359888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive diagnostic approach using galactomannan, targeted β-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients.
    Ceesay MM; Desai SR; Berry L; Cleverley J; Kibbler CC; Pomplun S; Nicholson AG; Douiri A; Wade J; Smith M; Mufti GJ; Pagliuca A
    Br J Haematol; 2015 Jan; 168(2):219-29. PubMed ID: 25179933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.
    Koo S; Bryar JM; Page JH; Baden LR; Marty FM
    Clin Infect Dis; 2009 Dec; 49(11):1650-9. PubMed ID: 19863452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difficulties in using 1,3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies--high frequency of false-positive results and their analysis.
    Racil Z; Kocmanova I; Lengerova M; Weinbergerova B; Buresova L; Toskova M; Winterova J; Timilsina S; Rodriguez I; Mayer J
    J Med Microbiol; 2010 Sep; 59(Pt 9):1016-1022. PubMed ID: 20488937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies.
    Hoenigl M; Strenger V; Buzina W; Valentin T; Koidl C; Wölfler A; Seeber K; Valentin A; Strohmeier AT; Zollner-Schwetz I; Raggam RB; Urban C; Lass-Flörl C; Linkesch W; Krause R
    J Antimicrob Chemother; 2012 Aug; 67(8):2029-33. PubMed ID: 22566591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of β-D-glucan for the diagnosis of invasive fungal infection in children with hematological malignancy.
    Guitard J; Tabone MD; Senghor Y; Cros C; Moissenet D; Markowicz K; Valin N; Leverger G; Hennequin C
    J Infect; 2016 Dec; 73(6):607-615. PubMed ID: 27452196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Odabasi Z; Mattiuzzi G; Estey E; Kantarjian H; Saeki F; Ridge RJ; Ketchum PA; Finkelman MA; Rex JH; Ostrosky-Zeichner L
    Clin Infect Dis; 2004 Jul; 39(2):199-205. PubMed ID: 15307029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early antigen diagnosis of invasive fungal infection in patients with hematological malignancies and patients receiving hematopoietic stem cell transplantation].
    Xu J; Sun ZM; Wang XB; Zhang XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1302-5. PubMed ID: 21129281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.